Terug
20
Ook genoteerd als
MCARY
OTC
Dagbereik
€ 15,88
€ 22,05
52-Weeksbereik
€ 15,88
€ 22,05
Volume
200
50D / 200D Gem.
€ 15,88
/
€ 16,01
Vorige Slotkoers
€ 15,88
Koershistorie
Financiële Trends
Sectorvergelijking
vs Consumer Cyclical sector mediaan (610 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,1 | 11,2 |
| P/B | 0,0 | 1,4 |
| ROE % | 30,5 | 10,7 |
| Net Margin % | 13,6 | 5,1 |
| Rev Growth 5Y % | 16,1 | 8,3 |
| D/E | 2,0 | 0,8 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 266,77
€ 252,96 – € 285,09
|
320 B | 1 |
| FY2029 |
€ 225,19
€ 213,53 – € 240,65
|
280 B | 1 |
| FY2028 |
€ 210,77
€ 199,85 – € 225,24
|
250 B | 1 |
Belangrijkste Punten
Revenue grew 16,07% annually over 5 years — strong growth
Earnings grew 94,00% over the past year
ROE of 30,52% indicates high profitability
Debt/Equity of 2,01 — high leverage
Negative free cash flow of -12,25B
P/E of 0,10 — trading at a low valuation
Groei
Revenue Growth (5Y)
16,07%
Revenue (1Y)2,79%
Earnings (1Y)94,00%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
30,52%
ROIC6,99%
Net Margin13,56%
Op. Margin14,45%
Veiligheid
Debt / Equity
2,01
Current Ratio1,32
Interest Coverage41,68
Waardering
P/E Ratio
0,10
P/B Ratio0,03
EV/EBITDA1,75
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,79% | Revenue Growth (3Y) | 5,81% |
| Earnings Growth (1Y) | 94,00% | Earnings Growth (3Y) | 41,35% |
| Revenue Growth (5Y) | 16,07% | Earnings Growth (5Y) | 46,17% |
| Profitability | |||
| Revenue (TTM) | 192,63B | Net Income (TTM) | 26,11B |
| ROE | 30,52% | ROA | 4,80% |
| Gross Margin | 71,77% | Operating Margin | 14,45% |
| Net Margin | 13,56% | Free Cash Flow (TTM) | -12,25B |
| ROIC | 6,99% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2,01 | Current Ratio | 1,32 |
| Interest Coverage | 41,68 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 0,10 | P/B Ratio | 0,03 |
| P/S Ratio | 0,01 | PEG Ratio | 0,17 |
| EV/EBITDA | 1,75 | Dividend Yield | 0,00% |
| Market Cap | 2,62B | Enterprise Value | 48,60B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 192,63B | 187,41B | 172,06B | 147,05B | 106,12B |
| Net Income | 26,11B | 13,46B | 13,07B | -7,57B | 5,72B |
| EPS (Diluted) | 154,85 | 79,01 | 77,36 | -47,33 | 35,15 |
| Gross Profit | 138,26B | 129,73B | 114,43B | 95,14B | 81,80B |
| Operating Income | 27,84B | 18,87B | 17,06B | -3,72B | 5,18B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 543,76B | 501,77B | 415,35B | 339,86B | 262,53B |
| Total Liabilities | 444,12B | 429,63B | 360,12B | 301,87B | 222,52B |
| Shareholders' Equity | 99,27B | 71,84B | 54,67B | 37,68B | 39,63B |
| Total Debt | 199,38B | 193,31B | 158,00B | 131,35B | 71,15B |
| Cash & Equivalents | 153,40B | 192,00B | 204,53B | 211,41B | 171,46B |
| Current Assets | 420,24B | 402,03B | 340,64B | 303,40B | 227,93B |
| Current Liabilities | 319,51B | 302,54B | 273,61B | 224,72B | 205,33B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#419 of 670
Recente Activiteit
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026